C3PNO COVID-19 Survey: Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) Survey of COVID-19 Risks/Effects, Substance Use, and HIV/AIDS | NLM

Disaster Information Management Research Center | NLM

C3PNO COVID-19 Survey: Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) Survey of COVID-19 Risks/Effects, Substance Use, and HIV/AIDS

05/01/2020 12:00 AM EDT

Source: National Institute on Drug Abuse (NIDA). Published: 5/1/2020. C3PNO fosters collaborations and data sharing across the National Institute on Drug Abuse (NIDA) cohorts. C3PNO manages and stimulates the use of the NIDA longitudinal cohorts and addresses high priority research on HIV/AIDS in the context of substance misuse. In response to the COVID-19 pandemic, we have crafted a cross-cutting survey of COVID-19 related risk behaviors and effects. Questions Adapted From: Various sources and original questions Population: Adults and Teens High Risk/Special/Unique Populations Multiple Groups Other Sexual or Gender Minorities Substance users, those at risk for or living with HIV/AIDS, men who have sex with men Length: Up to 65 questions but much shorter for non-active substance users Time to Complete: 15 minutes Mode of Administration: Online (e.g., computer-assisted interview) Telephone Administered by: Self Administered Trained Lay Examiner/Interviewer Special Considerations: May be conducted by interviewer but designed primarily for online survey Language(s): English (PDF)